Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- AdventHealth
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- The categorization of the RE-AIM model dimensions of Reach, Effectiveness, Adoption, Implementation, and Maintenance,
研究概览
简要总结
To evaluate a community-based outreach initiative for screening, diagnosis, and treatment of breast, lung, and prostate cancers in underserved adults using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) implementation science framework.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Adult aged 18 or older
- •Seeking care at a CRS or emergency department
- •Meets criteria for lung, breast, and/or prostate cancer screening, as outlined below:
- •Lung cancer: Adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years
- •Breast cancer: Women aged 40 to 74 years
- •Prostate cancer: Men aged 55 to 69 years
- •Receives a positive screening result for lung, breast, and/or prostate cancer at a study site
排除标准
- •Displays behavior disruptive to other patients or staff
- •Refusal to accept screening for breast, lung, and/or prostate cancers
结局指标
主要结局
The categorization of the RE-AIM model dimensions of Reach, Effectiveness, Adoption, Implementation, and Maintenance,
时间窗: From enrollment to the end of the 3 month follow-up for a total of 12 months
Reach will assess the percentage and characteristics of patients screened or excluded, as well as participant versus non-participant profiles. Effectiveness will measure the proportion of positive screens referred for confirmatory diagnostics and compare screening rates to Healthy People 2030 goals. Adoption will track provider education on breast, lung, and prostate cancer screening guidelines, uptake of screening practices, and staff engagement with navigation programs. Implementation will evaluate referrals to navigation, screening rates, and for positive screens: referral time, diagnostic barriers, treatment uptake, and clinical trial screening. Maintenance will examine primary outcomes at three months, progress toward HP2030 goals, attrition rates, and differences by patient characteristics.
次要结局
- Patient Satisfaction with Logistical Aspects of Navigation Scale (PSN-L)(From enrollment to the end of the 3 month follow-up for a total of 12 months)
- PROMIS Global Health (HR-QoL) scale(From enrollment to the end of the 3 month follow-up for a total of 12 months)